Pulmonary Arterial Hypertension (Guidelines on Diagnosis and Treatment of)

ESC Clinical Practice Guidelines

Topics:

Primary Pulmonary Hypertension

Current versions available to download

Publication dateVersionsReferencesSize
2004Full TextEHJ 2004;25:2243-2278363 KB
 Pocket guidelines
 PdaDownload the PDA Version
 Slideset3 MB

Current translated versions available to download:

Authors

Nazzareno Galié (Chairperson), Adam Torbicki (Poland), Robyn Barst (USA), Philippe Dartevelle (France), Sheila Haworth (UK), Tim Higenbottam (UK), Horst Olschewski (Germany), Andrew Peacock (UK), Giuseppe Pietra (Switzerland), Lewis J. Rubin (USA), Gerald Simonneau (Co-Chairperson) (France)

Table of contents: Full Text (ESC Clinical Practice Guidelines)

Clinical classification of pulmonary hypertension

  • Idiopathic pulmonary arterial hypertension
  • Risk factors and associated conditions
  • Pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis
  • Classification of congenital systemicto-pulmonary shunts

Pathology of pulmonary arterial hypertension

  • Pulmonary arteriopathy
  • Pulmonary occlusive venopathy
  • Pulmonary microvasculopathy

Pathogenesis of pulmonary arterial hypertension

Diagnostic strategy

  • Clinical suspicion of pulmonary hypertension
  • Detection of pulmonary hypertension
  • ECG
  • Chest radiograph
  • Transthoracic Doppler-echocardiography (TTE)

Pulmonary hypertension clinical class identification

  • Pulmonary function tests and arterial blood gases
  • Ventilation and perfusion (V/Q) lung scan
  • High resolution CT of the lung
  • Contrast enhanced spiral CT of the lung, pulmonary angiography and magnetic resonance imaging

Pulmonary arterial hypertension evaluation (type, exercise capacity, hemodynamics)

  • Blood tests and immunology
  • Abdominal ultrasound scan
  • Exercise capacity
  • Hemodynamics
  • Lung biopsy

Assessment of severity

  • Clinical variables
  • Exercise capacity
  • Echocardiographic parameters
  • Hemodynamics
  • Blood tests

Treatment

Introduction to level of evidence and grade of recommendation

General measures

  • Physical activity
  • Travel/altitude
  • Prevention of infections
  • Pregnancy, birth control and post-menopausal hormonal therapy
  • Haemoglobin levels
  • Concomitant medications
  • Psychological assistance
  • Elective surgery

Pharmacological treatment

  • Oral anticoagulant treatment
  • Diuretics
  • Oxygen
  • Digitalis and dobutamine
  • Calcium-channel blockers

Synthetic prostacyclin and prostacyclin analogues

  • Enpoprostenol
  • Treprostinil
  • Sodium beraprost
  • Iloprost
  • Intravenous Iloprost

Endothelin-1 receptor antagonists

  • Bosentan
  • Sitaxsentan
  • Ambrisentan

Type 5 phosphodiesterase inhibitors: Sildenafil

Combination therapy

Interventional procedures: Balloon atrial septostomy, Lung transplantation

Treatment algorithm

Previous versions

A complete list of ESC Clinical Practice Guidelines (current and previous versions) endorsed by ESC National Society Members is available here